Innoviva (INVA) Cash & Current Investments (2009 - 2026)
Innoviva posted quarterly Cash & Current Investments of $603.1 million for Q1 2026, up 89.0% year-on-year from $319.1 million in Q1 2025, and up 9.46% on a QoQ basis from $550.9 million in Q4 2025.
Innoviva (INVA) has 18 years of Cash & Current Investments data on file, last reported at $603.1 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 89.0% year-over-year to $603.1 million; the trailing twelve-month figure through Mar 2026 stood at $603.1 million (up 89.0% YoY), and the FY2025 full-year result was $550.9 million, up 80.66% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $603.1 million, up from $550.9 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $603.1 million in Q1 2026 and bottomed at $144.0 million in Q1 2023.
- The 5-year median for Cash & Current Investments is $283.6 million (2022), against an average of $299.5 million.
- The widest annual swing landed in 2022, when Cash & Current Investments jumped 555.45%; it then plunged 40.21% in 2023.
- A 5-year view of Cash & Current Investments shows it stood at $291.0 million in 2022, then plunged by 33.51% to $193.5 million in 2023, then jumped by 57.59% to $305.0 million in 2024, then jumped by 80.66% to $550.9 million in 2025, then advanced by 9.46% to $603.1 million in 2026.
- The last three Cash & Current Investments figures came in at $603.1 million (Q1 2026), $550.9 million (Q4 2025), and $476.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 603.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 603.09 Mn |
| Dec 31, 2025 | 550.94 Mn |
| Sep 30, 2025 | 476.51 Mn |
| Jun 30, 2025 | 397.53 Mn |
| Mar 31, 2025 | 319.09 Mn |
| Dec 31, 2024 | 304.96 Mn |
| Sep 30, 2024 | 260.63 Mn |
| Jun 30, 2024 | 217.00 Mn |
| Mar 31, 2024 | 178.36 Mn |
| Dec 31, 2023 | 193.51 Mn |
| Sep 30, 2023 | 180.00 Mn |
| Jun 30, 2023 | 173.03 Mn |
| Mar 31, 2023 | 144.05 Mn |
| Dec 31, 2022 | 291.05 Mn |
| Sep 30, 2022 | 301.07 Mn |
| Jun 30, 2022 | 283.58 Mn |
| Mar 31, 2022 | 216.80 Mn |
| Dec 31, 2021 | 201.53 Mn |
| Sep 30, 2021 | 135.12 Mn |
| Jun 30, 2021 | 43.27 Mn |
| Mar 31, 2021 | 282.89 Mn |
| Dec 31, 2020 | 246.49 Mn |
| Sep 30, 2020 | 479.19 Mn |
| Jun 30, 2020 | 417.15 Mn |
| Mar 31, 2020 | 383.95 Mn |
| Dec 31, 2019 | 350.85 Mn |
| Sep 30, 2019 | 297.20 Mn |
| Jun 30, 2019 | 249.66 Mn |
| Mar 31, 2019 | 192.18 Mn |
| Dec 31, 2018 | 114.91 Mn |
| Sep 30, 2018 | 55.48 Mn |
| Jun 30, 2018 | 107.54 Mn |
| Mar 31, 2018 | 56.46 Mn |
| Dec 31, 2017 | 129.08 Mn |
| Sep 30, 2017 | 168.19 Mn |
| Jun 30, 2017 | 135.63 Mn |
| Mar 31, 2017 | 169.81 Mn |
| Dec 31, 2016 | 150.43 Mn |
| Sep 30, 2016 | 148.97 Mn |
| Jun 30, 2016 | 153.87 Mn |
| Mar 31, 2016 | 168.19 Mn |
| Dec 31, 2015 | 187.28 Mn |
| Sep 30, 2015 | 206.19 Mn |
| Jun 30, 2015 | 229.26 Mn |
| Mar 31, 2015 | 251.14 Mn |
| Dec 31, 2014 | 240.50 Mn |
| Sep 30, 2014 | 263.11 Mn |
| Jun 30, 2014 | 334.48 Mn |
| Mar 31, 2014 | 370.92 Mn |
| Dec 31, 2013 | 465.13 Mn |
| Sep 30, 2013 | 506.15 Mn |
| Jun 30, 2013 | 443.01 Mn |
| Mar 31, 2013 | 459.06 Mn |
| Dec 31, 2012 | 248.49 Mn |
| Sep 30, 2012 | 273.44 Mn |
| Jun 30, 2012 | 295.49 Mn |
| Mar 31, 2012 | 200.16 Mn |
| Dec 31, 2011 | 240.92 Mn |
| Sep 30, 2011 | 265.17 Mn |
| Jun 30, 2011 | 283.89 Mn |
| Mar 31, 2011 | 147.87 Mn |
| Dec 31, 2010 | 309.60 Mn |
| Sep 30, 2010 | 63.10 Mn |
| Jun 30, 2010 | 69.72 Mn |
| Dec 31, 2009 | 47.54 Mn |